Anthony M. Smith
机构: National Institute for Communicable Diseases, South Africa
每年引用次数
引用次数
引用: 5,926
H-指数: 41
I10-指数 : 88
出版物: 132
Cluster of an erythromycin-resistant variant of the Spanish multiply resistant 23F clone of Streptococcus pneumoniae in South Africa.
K. P. Klugman , T. J. Coffey , A. Smith , A. Wasas
European Journal of Clinical Microbiology & Infectious Diseases 13 ( 2) 171 -174
46
1994
Characterization of cholera outbreak isolates from Namibia, December 2006 to February 2007
A. M. SMITH , K. H. KEDDY , L. De WEE
Epidemiology and Infection 136 ( 9) 1207 -1209
16
2008
Bacterial Gastroenteritis
ANTHONY M SMITH
Gastrointestinal Diseases and Their Associated Infections 151 -151
2019
Escherichia coli O104 associated with human diarrhea, South Africa, 2004-2011.
Nomsa P. Tau , Parastu Meidany , Anthony M. Smith , Arvinda Sooka
Emerging Infectious Diseases 18 ( 8) 1314 -1317
14
2012
Alterations in PBP 1A Essential for High-Level Penicillin Resistance in Streptococcus pneumoniae
Anthony M. Smith , Keith P. Klugman
Antimicrobial Agents and Chemotherapy 42 ( 6) 1329 -1333
110
1998
Emergence of a Pneumococcal Clone with Cephalosporin Resistance and Penicillin Susceptibility
Anthony M. Smith , Roelof F. Botha , Hendrik J. Koornhof , Keith P. Klugman
Antimicrobial Agents and Chemotherapy 45 ( 9) 2648 -2650
20
2001
Alterations in MurM, a cell wall muropeptide branching enzyme, increase high-level penicillin and cephalosporin resistance in Streptococcus pneumoniae.
Anthony M. Smith , Keith P. Klugman
Antimicrobial Agents and Chemotherapy 45 ( 8) 2393 -2396
72
2001
Prevalence and antibiotic susceptibility patterns of enteric bacterial pathogens in human and non-human sources in an urban informal settlement in Cape Town, South Africa.
John Bosco Kalule , Anthony M. Smith , Mjikisile Vulindhlu , Nomsa P. Tau
BMC Microbiology 19 ( 1) 244 -244
1
2019
Non-Penicillin-Binding protein mediated high-level penicillin and cephalosporin resistance in a Hungarian clone of Streptococcus pneumoniae.
Anthony M. Smith , Keith P. Klugman
Microbial Drug Resistance 6 ( 2) 105 -110
31
2000
Analysis of penicillin-binding protein 1b and 2a genes from Streptococcus pneumoniae.
Mignon du Plessis , Anthony M. Smith , Keith P. Klugman
Microbial Drug Resistance 6 ( 2) 127 -131
14
2000
Epidemiological investigation of a typhoid fever outbreak in Sekhukhune District, Limpopo province, South Africa – 2017
Unarine B. Makungo , Tshilidzi E. Ramutshila , Mantwa C. Mabotja , Juno Thomas
Southern African Journal of Infectious Diseases 35 ( 1) 7
2020
Meningococcal disease in South Africa, 1999-2002.
Garry B. Coulson , Anne von Gottberg , Mignon du Plessis , Anthony M. Smith
Emerging Infectious Diseases 13 ( 2) 273 -281
38
2007
Application of pbp1A PCR in Identification of Penicillin-Resistant Streptococcus pneumoniae
Mignon du Plessis , Anthony M. Smith , Keith P. Klugman
Journal of Clinical Microbiology 37 ( 3) 628 -632
28
1999
High-Level Telithromycin Resistance in a Clinical Isolate of Streptococcus pneumoniae
Nicole Wolter , Anthony M. Smith , Donald E. Low , Keith P. Klugman
Antimicrobial Agents and Chemotherapy 51 ( 3) 1092 -1095
24
2007
In Vitro Evaluation of the Antimicrobial Activity of Ceftaroline against Cephalosporin-Resistant Isolates of Streptococcus pneumoniae
Lesley McGee , Donald Biek , Yigong Ge , Magderie Klugman
Antimicrobial Agents and Chemotherapy 53 ( 2) 552 -556
55
2009
Site-specific mutagenesis analysis of PBP 1A from a penicillin-cephalosporin-resistant pneumococcal isolate.
Anthony M. Smith , Keith P. Klugman
Antimicrobial Agents and Chemotherapy 47 ( 1) 387 -389
29
2003
Amino Acid Mutations Essential to Production of an Altered PBP 2X Conferring High-Level β-Lactam Resistance in a Clinical Isolate of Streptococcus pneumoniae
Anthony M. Smith , Keith P. Klugman
Antimicrobial Agents and Chemotherapy 49 ( 11) 4622 -4627
32
2005
Altered PBP 2A and Its Role in the Development of Penicillin, Cefotaxime, and Ceftriaxone Resistance in a Clinical Isolate of Streptococcus pneumoniae
Anthony M. Smith , Charles Feldman , Orietta Massidda , Kerrigan McCarthy
Antimicrobial Agents and Chemotherapy 49 ( 5) 2002 -2007
23
2005
Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus.
Nicole Wolter , Anthony M. Smith , David J. Farrell , William Schaffner
Antimicrobial Agents and Chemotherapy 49 ( 8) 3554 -3557
131
2005
Heterogeneous Macrolide Resistance and Gene Conversion in the Pneumococcus
Nicole Wolter , Anthony M. Smith , David J. Farrell , Keith P. Klugman
Antimicrobial Agents and Chemotherapy 50 ( 1) 359 -361
14
2006